Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells

Journal of Zhejiang University: Science B

Volumn 15, Issue 8, 2014, Pages 692-700

  Ng, Pek Leng ^a   Rajab, Nor Fadilah ^a   Then, Sue Mian ^a,b   Mohd Yusof, Yasmin Anum ^c   Wan Ngah, Wan Zurinah ^a,c   Pin, Kar Yong ^d   Looi, Mee Lee ^e  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

^c DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^d FOREST RESEARCH INSTITUTE MALAYSIA   (Malaysia)

^e TAYLOR S UNIVERSITY   (Malaysia)

Author keywords

5 Fluorouracil; Herb drug interaction; Isobologram analysis; Piper betle L.; Piperaceae

Indexed keywords

ASCORBIC ACID; BETEL EXTRACT; FLUOROURACIL; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CHEMICAL INTERACTION; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; HCT116 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HT 29 CELL LINE; HUMAN; HUMAN CELL; IC 50; PLANT LEAF; PRIORITY JOURNAL; COLONIC NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; HERB DRUG INTERACTION; MALAYSIA; PATHOLOGY; PHYTOTHERAPY; PIPER BETLE;

APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; HCT116 CELLS; HERB-DRUG INTERACTIONS; HT29 CELLS; HUMANS; MALAYSIA; PHYTOTHERAPY; PIPER BETLE; PLANT EXTRACTS; PLANT LEAVES;

EID: 84903694918     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1300303     Document Type: Article

References (43)

1. Ahmad, M., Usman, M., Madni, A., et al., 2011. A fast and simple HPLC-UV method for simultaneous determination of three anti-cancer agents in plasma of breast cancer patients and its application to clinical pharmacokinetics. Afr. J. Pharm. Pharmacol., 5(7):915-922.
2. Arambewela, L., Arawwawala, M., Rajapaksa, D., 2006. Piper betle: a potential natural antioxidant. Int. J. Food Sci. Technol., 41(s1):10-14. [doi:10.1111/j.1365-2621.2006.01227.x] (Pubitemid 44181396)
3. Boyer, J., McLean, E.G., Aroori, S., et al., 2004. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin. Cancer Res., 10(6):2158-2167. [doi:10.1158/1078-0432.CCR-03-0362] (Pubitemid 38375578)
4. Bunz, F., Hwang, P.M., Torrance, C., et al., 1999. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest., 104(3):263-269. [doi:10.1172/JCI6863]
5. Cabrera, J., Mancuso, M., Cabrera-Franquiz, F., et al., 2011. Stability and compatibility of the mixture of tramadol, ketorolac, metoclopramide and ranitidine in a solution for intravenous perfusion. Farm. Hosp., 35(2):80-83 (in Spanish). [doi:10.1016/j.farma.2010.01.007]
6. Chakraborty, J.B., Mahato, S.K., Joshi, K., et al., 2012. Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. Cancer Sci., 103(1):88-99. [doi:10.1111/j.1349-7006.2011.02107.x]
7. Chang, M., Uang, B., Wu, H.L., et al., 2002. Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species. Brit. J. Pharmacol., 135(3):619-630. [doi:10.1038/sj.bjp.0704492] (Pubitemid 34177639)
8. Chou, T.C., 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev., 58(3):621-681. [doi:10.1124/pr.58.3.10]
9. Esimone, C.O., 2011. Drug-drug and herb-drug interaction - a comment. J. Res. Nat. Dev., 9(1):47-59.
10. Fathilah, A.R., Sujata, R., Norhanom, A.W., et al., 2010. Antiproliferative activity of aqueous extract of Piper betle L. and Psidium guajava L. on KB and HeLa cell lines. J. Med. Plants Res., 4(11):987-990.
11. Felth, J., Rickardson, L., Rosen, J., et al., 2009. Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs. J. Nat. Prod., 72(11):1969-1974. [doi:10.1021/ np900210m]
12. Fishbein, A.B., Wang, C.Z., Li, X.L., et al., 2009. Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: comparison between white and red ginseng. Arch. Pharm. Res., 32(4):505-513. [doi:10.1007/s12272-009-1405-9]
13. Guha, P., 2006. Betel leaf: the neglected green gold of India. J. Hum. Ecol., 19(2):87-93.
14. Hemamalini, V., Dass Prakash, M.V., Sivaramakrishnan, S., 2012. Evaluation of the in vitro antioxidant, anti-enteropathogenic and anticancer efficacy of natural and synthetic hydroxychavicol. Int. J. Medicobiol. Res., 1(5):250-254.
15. Hiss, D.C., Gabriels, G.A., Folb, P.I., 2007. Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. Cancer Cell Int., 7(1):5. [doi:10.1186/1475-2867-7-5]
16. Hörmann, V., Kumi-Diaka, J., Durity, M., et al., 2012. Anticancer activities of genistein-topotecan combination in prostate cancer cells. J. Cell. Mol. Med., 16(11):2631-2636. [doi:10.1111/j.1582-4934.2012.01576.x]
17. Hussin, A.H., 2001. Adverse effects of herbs and drug-herbal interactions. Malays. J. Pharm., 1(2):39-44.
18. Jeng, J., Chen, S., Liao, C., et al., 2002. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. Free Radic. Biol. Med., 32(9):860-871. [doi:10.1016/S0891-5849(02)00749-9] (Pubitemid 34439256)
19. Jeng, J.H., Wang, Y.J., Chang, W.H., et al., 2004. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. Cell. Mol. Life Sci., 61(1):83-96. [doi:10.1007/s00018-003-3272-8] (Pubitemid 38121902)
20. Jin, J., Huang, M., Wei, H.L., et al., 2002. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel7402. World J. Gastroenterol., 8(6):1029-1034. (Pubitemid 35446415)
21. Kinsella, A., Smith, D., Pickard, M., 1997. Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. Brit. J. Cancer, 75(7):935-945. [doi:10.1038/bjc.1997.164] (Pubitemid 27122610)
22. Klampfer, L., Swaby, L.A., Huang, J., et al., 2005. Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis. Oncogene, 24(24):3932-3941. [doi:10.1038/sj.onc.1208552] (Pubitemid 40896405)
23. Kumar, N., Misra, P., Dube, A., et al., 2010. Piper betle Linn. a maligned Pan-asiatic plant with an array of pharmacological activities and prospects for drug discovery. Curr. Sci., 99(7):922-932.
24. Kumar, S., Choudhary, S., Singh, N., et al., 2012. Combination of natural drugs: an emerging trend in cancer chemotherapy. J. Drug Deliv. Ther., 2(3):97-105.
25. Mader, R.M., Müller, M., Steger, G.G., 1998. Resistance to 5-fluorouracil. Gen. Pharmacol., 31(5):661-666. [doi:10.1016/S0306-3623(98) 00191-8] (Pubitemid 28520040)
26. Majumdar, A.P., Banerjee, S., Nautiyal, J., et al., 2009. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr. Cancer, 61(4):544-553. [doi:10.1080/01635580902752262]
27. Molyneux, P., 2004. The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J. Sci. Technol., 26(2):211-219.
28. Nakagawa, Y., Suzuki, T., Nakajima, K., et al., 2009. Biotransformation and cytotoxic effects of hydroxychavicol, an intermediate of safrole metabolism, in isolated rat hepatocytes. Chem. Biol. Interact., 180(1):89-97. [doi:10.1016/j.cbi.2009.02.003]
29. Newton, D.W., 2009. Drug incompatibility chemistry. Am. J. Health Syst. Pharm., 66(4):348-357. [doi:10.2146/ajhp080059]
30. Noordhuis, P., Holwerda, U., van der Wilt, C., et al., 2004. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann. Oncol., 15(7):1025-1032. [doi:10.1093/annonc/mdh264] (Pubitemid 39089778)
31. Pin, K., Chuah, A.L., Rashid, A.A., et al., 2010. Antioxidant and anti-inflammatory activities of extracts of betel leaves (Piper betle) from solvents with different polarities. J. Trop. For. Sci., 22(4):448-455.
32. Pin, K.Y., Ilicali, C., Luqman Chuah, A., et al., 2011. Modelling of freezing kinetics of extract of betel leaves (Piper betle L.). Int. J. Food Eng., 7(1):Art. 15. [doi:10.2202/1556-3758.1692]
33. Pizzorno, G., Diasio, R.B., Cheng, Y.C., 2009. Cancer Medicine. People's Medical Publishing House-USE, USA.
34. Pourcel, L., Routaboul, J.M., Cheynier, V., et al., 2007. Flavonoid oxidation in plants: from biochemical properties to physiological function. Trends Plant Sci., 12(1):29-36. [doi:10.1016/j.tplants.2006.11.006] (Pubitemid 46096808)
35. Renuka, G., Thiruvengadarajan, V.S., Amruthkumar, N., et al., 2011. A review on herb-drug interactions. Int. J. Pharm. Res. Dev., 3(3):136-153.
36. Slovin, S., 2012. Chemotherapy and immunotherapy combination in advanced prostate cancer. Clin. Adv. Hematol. Oncol., 10(2):90-100.
37. Tallarida, R.J., Raffa, R.B., 1996. Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram. Life Sci., 58(2):23-28. [doi:10.1016/0024-3205(95)02271-6]
38. Tang, X.Y., Zhu, Y.Q., Tao, W.H., et al., 2007. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma. Postgrad. Med. J., 83(979):338-343. [doi:10.1136/pgmj.2006.055426]
39. Tong, J., Xie, G., He, J., et al., 2011. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer. J. Biomed. Biotechnol., 2011:740564. [doi:10.1155/2011/740564]
40. Wang, C.Z., Yuan, C.S., 2008. Potential role of ginseng in the treatment of colorectal cancer. Am. J. Chin. Med., 36(6):1019-1028. [doi:10.1142/ S0192415X08006545]
41. Yamai, H., Sawada, N., Yoshida, T., et al., 2009. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int. J. Cancer, 125(4):952-960. [doi:10.1002/ijc.24433]
42. Young, S.C., Wang, C.J., Hsu, J.D., et al., 2006. Increased sensitivity of HepG2 cells toward the cytotoxicity of cisplatin by the treatment of Piper betel leaf extract. Arch. Toxicol., 80(6):319-327. [doi:10.1007/s00204-005-0051- 3]
43. Zong, W.X., Thompson, C.B., 2006. Necrotic death as a cell fate. Genes Dev., 20(1):1-15. [doi:10.1101/gad.1376506] (Pubitemid 43042662)